bibliographic entry 8105535 [be/8105535]
https://w3id.org/oc/corpus/be/8105535

is a

• bibliographic reference

content

• ClinicalTrials.gov. An efficacy and safety study of daratumumab in patients with multiple myeloma who have received at least 3 prior lines of therapy (Including a proteasome inhibitor [PI] and immunomodulatory drug [IMiD]) or are double refractory to a PI and an IMiD. Available at http://www.clinicaltrials.gov/ct2/show/NCT01985126?term=NCT01985126&rank=1. (Accessed 14 May 2015).

references

• https://w3id.org/oc/corpus/br/6250415